MHRA inspects Alkem Laboratories’ Bioequivalence Center at Taloja

14 May 2022 Evaluate

The Medicines and Healthcare products Regulatory Agency (MHRA) had conducted an online inspection at Alkem Laboratories’ Bioequivalence Center located at Taloja, Maharashtra from January 31, 2022 to February 4, 2022 and February 8, 2022 to February 10, 2022.

As per the Good Clinical Practice (GCP) Inspection Statement dated May 12, 2022, there were no critical or major observations identified and the said inspection stands closed.

Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.

Alkem Laboratories Share Price

5479.45 47.60 (0.88%)
23-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1814.50
Dr. Reddys Lab 1340.80
Cipla 1476.45
Lupin 2160.20
Zydus Lifesciences 972.95
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.